Menopur is hard to find in 2026 due to supply shortages and rising demand. Learn why this fertility drug is scarce and what you can do to get it.
You've got your fertility treatment plan in hand, your cycle is about to start, and then your pharmacy tells you they don't have Menopur in stock. Sound familiar? You're far from alone. Thousands of patients across the country have been dealing with the same frustrating situation in recent years — and it's only gotten more stressful as supply issues continue into 2026.
In this post, we'll explain what Menopur is, why it's been so difficult to find, and — most importantly — what you can do about it right now.
Menopur is the brand name for Menotropins, an injectable fertility medication made by Ferring Pharmaceuticals. It contains equal parts of two key hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Together, these hormones stimulate the ovaries to develop multiple mature eggs during a fertility treatment cycle.
Menopur is most commonly prescribed as part of in vitro fertilization (IVF) protocols, though it's also used for ovulation induction and intrauterine insemination (IUI). It's administered as a daily subcutaneous injection, typically for 5 to 12 days, and requires close monitoring by a reproductive endocrinologist.
For many patients, Menopur is a critical part of their treatment plan — which is why running into stock issues can be so distressing. To learn more about how this medication works in detail, see our guide on how Menopur works.
There's no single reason Menopur has been difficult to locate. Instead, it's a combination of factors that have created a perfect storm of scarcity.
The number of IVF cycles performed in the United States has been climbing steadily. More states are mandating insurance coverage for fertility treatments, and more people are choosing to start families later in life. Both trends have dramatically increased the demand for injectable gonadotropins like Menopur. Manufacturing simply hasn't kept pace.
Unlike recombinant fertility drugs such as Gonal-F or Follistim, Menopur is derived from the urine of postmenopausal women. This biological sourcing makes the manufacturing process more complex, harder to scale, and subject to supply variability. You can't just flip a switch and make more — it takes time to increase production capacity.
Menopur is the only widely available human menopausal gonadotropin (hMG) product on the U.S. market. Previous competitors like Repronex and Bravelle have been discontinued, leaving Ferring Pharmaceuticals as essentially the sole supplier. With no generic or biosimilar available, there's no backup when supply runs short.
Menopur requires refrigeration and is often dispensed through specialty fertility pharmacies rather than your neighborhood drugstore. Large retail pharmacy chains like CVS or Walgreens may not stock it consistently, and even specialty pharmacies can run out during peak demand periods (spring and early summer tend to be busiest for IVF cycles).
If you're having trouble finding Menopur, don't panic. Here are practical steps you can take today:
Medfinder helps you search for Menopur across pharmacies in your area, showing you which locations currently have it in stock. It's free to use and can save you hours of calling around. For a detailed walkthrough, check out our post on how to find Menopur in stock near you.
Specialty pharmacies that focus on fertility medications — like Freedom Fertility, Encompass Fertility, or MDR Pharmacy — are far more likely to have Menopur in stock than retail chains. Your fertility clinic likely has relationships with several and can point you in the right direction.
If Menopur truly isn't available, your reproductive endocrinologist may be able to adjust your protocol. Alternatives like Gonal-F (follitropin alfa) or Follistim AQ (follitropin beta) provide FSH stimulation, and your doctor can add supplemental LH if needed. Read more about your options in our post on alternatives to Menopur.
If your cycle start date is still a few weeks away, let your clinic and pharmacy know early so they can begin sourcing Menopur before you need it. Early communication is often the difference between a smooth start and a stressful scramble.
Sometimes the issue isn't just availability — it's cost. A single vial of Menopur costs roughly $90 to $130, and a full IVF cycle can require 20 to 40 vials ($1,800 to $5,200+). For tips on reducing costs, see our guide on how to save money on Menopur.
Dealing with a medication shortage during fertility treatment is incredibly stressful — we understand that. The challenges with Menopur availability in 2026 are real, but they're not insurmountable. By using tools like Medfinder, working closely with your fertility clinic, and exploring your options early, you can give yourself the best chance of staying on track with your treatment plan.
For the latest on supply status, check our Menopur shortage update for 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
